Ref: UKHSA publications gateway number GOV-11052PDF, 688 KB, 77 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email arsac@phe.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.
Details
This guidance to good clinical practice for nuclear medicine in the UK is the advice of the Administration of Radioactive Substances Advisory Committee (ARSAC).
The January 2022 version contains notable updates from the previous version as detailed on page 1.
Published 17 April 2014 Last updated 26 January 2022 +show all updates
Updated 'Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources' (see page 1 for the latest changes).
Edited Section 3: Applying for a practitioner licence.
Added February update.
Added September 2020 update for Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources.
Added April 2020 update for Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources.
Updated 'Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources'.
Updated notes to clarify the licencing process.
Replaced 'notes for guidance' document and updated detail text.